Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017)
Armata Pharmaceuticals (ARMP) reported Change in Receivables of -$2000.0 for Q2 2017, down 150.0% on a YoY basis from $4000.0 in Q2 2016, and up 80.0% sequentially from -$10000.0 in Q1 2017.
Armata Pharmaceuticals (ARMP) Change in Receivables (2013 - 2017) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 5 years of Change in Receivables data on file, last reported at -$2000.0 in Q2 2017.
- For the quarter ending Q2 2017, Change in Receivables fell 150.0% year-over-year to -$2000.0; the trailing twelve-month figure through Sep 2017 stood at -$11000.0 (up 31.25% YoY), and the FY2020 full-year result was $467000.0, changed N/A from the prior year.
- Change in Receivables grew to -$2000.0 in Q2 2017, from -$10000.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $129000.0 in Q2 2013 to a low of -$140000.0 in Q4 2013.
- A 5-year average of -$588.24 and a median of $4000.0 in 2014 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 152.14% in 2014 and tumbled 2600.0% in 2015, its largest moves.
- Tracing ARMP's Change in Receivables over 5 years: stood at -$140000.0 in 2013, then jumped by 152.14% to $73000.0 in 2014, then climbed by 16.44% to $85000.0 in 2015, then plunged by 98.82% to $1000.0 in 2016, then tumbled by 300.0% to -$2000.0 in 2017.
- Business Quant data shows ARMP's Change in Receivables at -$2000.0 in Q2 2017, -$10000.0 in Q1 2017, and $1000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -2,000.00 |
| Jun 30, 2017 | -2,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Mar 31, 2017 | -10,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Sep 30, 2016 | 6,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Jun 30, 2016 | 4,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Mar 31, 2016 | -111,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Dec 31, 2015 | 85,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Sep 30, 2015 | 40,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Mar 31, 2015 | -100,000.00 |
| Dec 31, 2014 | 73,000.00 |
| Dec 31, 2014 | 73,000.00 |